Etiology and pathogenesis of age-related macular degeneration;Ätiologie und Pathogenese der altersabhängigen Makuladegeneration

Ophthalmologe

Volumn 110, Issue 4, 2013, Pages 377-389

  Herrmann, P ^a,b   Holz, F G ^a   Charbel Issa, P ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Blindness; Complement system; Environmental factors; Genetics; Risk profile

Indexed keywords

EID: 84876447512     PISSN: 0941293X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00347-012-2779-5     Document Type: Article

References (38)

1. Vingerling JR, Klaver CC, Hofman A et al (1995) Epidemiology of age-related maculopathy. Epidemiol Rev 17:347-360
2. Sparrow JR, Nakanishi K, Parish CA (2000) The lipofuscin fluorophore A2E mediates blue light-induced damage to retinal pigmented epithelial cells. Invest Ophthalmol Vis Sci 41:1981-1989
3. Holz FG, Sheraidah G, Pauleikhoff D et al (1994) Analysis of lipid deposits extracted from human macular and peripheral Bruch's membrane. Arch Ophthalmol 112:402-406
4. van der Schaft TL, Mooy CM, de Bruijn WC et al (1993) Early stages of age-related macular degeneration: an immunofluorescence and electron microscopy study. Br J Ophthalmol 77:657-661
5. Schmitz-Valckenberg S, Steinberg JS, Fleckenstein M et al (2010) Combined confocal scanning laser ophthalmoscopy and spectral-domain optical coherence tomography imaging of reticular drusen associated with age-related macular degeneration. Ophthalmology 117:1169-1176
6. Smith W, Assink J, Klein R et al (2001) Risk factors for age-related macular degeneration: pooled findings from three continents. Ophthalmology 108:697-704
7. Chakravarthy U, Augood C, Bentham GC et al (2007) Cigarette smoking and age-related macular degeneration in the EUREYE Study. Ophthalmology 114:1157-1163
8. Curcio CA, Millican CL, Bailey T et al (2001) Accumulation of cholesterol with age in human Bruch's membrane. Invest Ophthalmol Vis Sci 42:265-274
9. Klein R, Klein BE, Jensen SC et al (1997) The five-year incidence and progression of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology 104:7-21
10. Tomany SC, Cruickshanks KJ, Klein R et al (2004) Sunlight and the 10-year incidence of age-related maculopathy: the Beaver Dam Eye Study. Arch Ophthalmol 122:750-757
11. Casparis H, Lindsley K, Kuo IC et al (2012) Surgery for cataracts in people with age-related macular degeneration. Cochrane Database Syst Rev 6:CD006757
12. Age-Related Eye Disease Study Research Group (2001) A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol 119:1417-1436
13. Seddon JM, Cote J, Page WF et al (2005) The US twin study of age-related macular degeneration: relative roles of genetic and environmental influences. Arch Ophthalmol 123:321-327
14. Klaver CC, Wolfs RC, Assink JJ et al (1998) Genetic risk of age-related maculopathy. Population-based familial aggregation study. Arch Ophthalmol 116:1646-1651
15. Scholl HP, Fleckenstein M, Charbel Issa P et al (2007) An update on the genetics of age-related macular degeneration. Mol Vis 13:196-205
16. Charbel Issa P, Chong NV, Scholl HP (2011) The significance of the complement system for the pathogenesis of age-related macular degeneration -current evidence and translation into clinical application. Graefes Arch Clin Exp Ophthalmol 249:163-174
17. Hageman GS, Hancox LS, Taiber AJ et al (2006) Extended haplotypes in the complement factor H (CFH) and CFH-related (CFHR) family of genes protect against age-related macular degeneration: characterization, ethnic distribution and evolutionary implications. Ann Med 38:592-604
18. Schmidt S, Klaver C, Saunders A et al (2002) A pooled case-control study of the apolipoprotein E (APOE) gene in age-related maculopathy. Ophthalmic Genet 23:209-223
19. Neale BM, Fagerness J, Reynolds R et al (2010) Genome-wide association study of advanced age-related macular degeneration identifies a role of the hepatic lipase gene (LIPC). Proc Natl Acad Sci U S A 107:7395-7400
20. Chen W, Stambolian D, Edwards AO et al (2010) Genetic variants near TIMP3 and high-density lipoprotein-associated loci influence susceptibility to age-related macular degeneration. Proc Natl Acad Sci U S A 107:7401-7406
21. Schmidt S, Hauser MA, Scott WK et al (2006) Cigarette smoking strongly modifies the association of LOC387715 and age-related macular degeneration. Am J Hum Genet 78:852-864
22. Klein ML, Francis PJ, Rosner B et al (2008) CFH and LOC387715/ARMS2 genotypes and treatment with antioxidants and zinc for age-related macular degeneration. Ophthalmology 115:1019-1025
23. Ho L, van Leeuwen R, Witteman JC et al (2011) Reducing the genetic risk of age-related macular degeneration with dietary antioxidants, zinc, and omega-3 fatty acids: the Rotterdam study. Arch Ophthalmol 129:758-766
24. Weismann D, Hartvigsen K, Lauer N et al (2011) Complement factor H binds malondialdehyde epitopes and protects from oxidative stress. Nature 478:76-81
25. Hagstrom SA, Ying GS, Pauer GJ et al (2013) Pharmacogenetics for genes associated with age-related macular degeneration in the Comparison of AMD Treatments Trials (CATT). Ophthalmology [Epub ahead of print]
26. Scholl HP, Charbel Issa P, Walier M et al (2008) Systemic complement activation in age-related macular degeneration. PLoS One 3:e2593
27. Coffey PJ, Gias C, McDermott CJ et al (2007) Complement factor H deficiency in aged mice causes retinal abnormalities and visual dysfunction. Proc Natl Acad Sci U S A 104:16651-16656
28. Clark SJ, Perveen R, Hakobyan S et al (2010) Impaired binding of the age-related macular degeneration-associated complement factor H 402H allotype to Bruch's membrane in human retina. J Biol Chem 285:30192-30202
29. Yi X, Ogata N, Komada M et al (1997) Vascular endothelial growth factor expression in choroidal neovascularization in rats. Graefes Arch Clin Exp Ophthalmol 235:313-319
30. Hageman GS, Luthert PJ, Victor Chong NH et al (2001) An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and age-related macular degeneration. Prog Retin Eye Res 20:705-732
31. Combadiere C, Feumi C, Raoul W et al (2007) CX3CR1-dependent subretinal microglia cell accumulation is associated with cardinal features of age-related macular degeneration. J Clin Invest 117:2920-2928
32. Luhmann UF, Robbie S, Munro PM et al (2009) The drusenlike phenotype in aging Ccl2-knockout mice is caused by an accelerated accumulation of swollen autofluorescent subretinal macrophages. Invest Ophthalmol Vis Sci 50:5934-5943
33. Francis PJ, Schultz DW, Hamon S et al (2007) Haplotypes in the complement factor H (CFH) gene: associations with drusen and advanced age-related macular degeneration. PLoS One 2:e1197
34. Klein R, Klein BE, Knudtson MD et al (2007) Fifteen-year cumulative incidence of age-related macular degeneration: the Beaver Dam Eye Study. Ophthalmology 114:253-262
35. Holz FG, Bellman C, Staudt S et al (2001) Fundus autofluorescence and development of geographic atrophy in age-related macular degeneration. Invest Ophthalmol Vis Sci 42:1051-1056
36. Ambati J, Ambati BK, Yoo SH et al (2003) Age-related macular degeneration: etiology, pathogenesis, and therapeutic strategies. Surv Ophthalmol 48:257-293
37. Spaide RF (2006) Rationale for combination therapies for choroidal neovascularization. Am J Ophthalmol 141:149-156
38. Krzystolik MG, Afshari MA, Adamis AP et al (2002) Prevention of experimental choroidal neovascularization with intravitreal anti-vascular endothelial growth factor antibody fragment. Arch Ophthalmol 120:338-346